JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hove, E. L.
Right arrow Articles by Hardin, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hove, E. L.
Right arrow Articles by Hardin, J. O.
Journal of Pharmacology And Experimental Therapeutics, Vol. 106, Issue 1, 88-93, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


CREATINE SYNTHESIS BY RAT LIVER, IN VITRO, AS INFLUENCED BY CARBON TETRACHLORIDE AND DIETARY VITAMIN E

E. L. Hove 1 and J. O. Hardin 2

1 Department of Animal Husbandry and Nutrition, Alabama Polytechnic Institute, Auburn, Alabama
2 Ralston Purina Research Laboratories, St. Louis, Mo.

Carbon tetrachloride injected into young rats on a 10 per cent casein diet deficient in vitamin E resulted in a decrease, to less than one-third of the control value, in the ability of liver slice to synthesize creatine from guanidoacetic acid and methionine. Muscle creatine diminished significantly, urine creatine increased three-fold, and liver creatine increased slightly. The same changes to a lesser degree were noted in vitamin E deficient rats.

Dietary vitamin E prevented, or markedly lessened the changes in creatine metabolism due to carbon tetrachloride. These results were interpreted as showing that under the conditions employed, the toxicity of carbon tetrachloride was due to precipitation of an acute vitamin E deficiency.

The level of carbon tetrachloride injected (0.05 ml./wk.) was sufficiently low so that no extensive damage to cellular composition or architecture of the liver occurred.

Submitted on May 8, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.